BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 31605691)

  • 1. Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy.
    Dubinsky V; Reshef L; Bar N; Keizer D; Golan N; Rabinowitz K; Godny L; Yadgar K; Zonensain K; Tulchinsky H; Gophna U; Dotan I
    Gastroenterology; 2020 Feb; 158(3):610-624.e13. PubMed ID: 31605691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.
    Reshef L; Kovacs A; Ofer A; Yahav L; Maharshak N; Keren N; Konikoff FM; Tulchinsky H; Gophna U; Dotan I
    Gastroenterology; 2015 Sep; 149(3):718-27. PubMed ID: 26026389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
    Gosselink MP; Schouten WR; van Lieshout LM; Hop WC; Laman JD; Ruseler-van Embden JG
    Dis Colon Rectum; 2004 Sep; 47(9):1519-25. PubMed ID: 15486751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between fecal hydrogen sulfide production and pouchitis.
    Ohge H; Furne JK; Springfield J; Rothenberger DA; Madoff RD; Levitt MD
    Dis Colon Rectum; 2005 Mar; 48(3):469-75. PubMed ID: 15747080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.
    Machiels K; Sabino J; Vandermosten L; Joossens M; Arijs I; de Bruyn M; Eeckhaut V; Van Assche G; Ferrante M; Verhaegen J; Van Steen K; Van Immerseel F; Huys G; Verbeke K; Wolthuis A; de Buck Van Overstraeten A; D'Hoore A; Rutgeerts P; Vermeire S
    Gut; 2017 Jan; 66(1):79-88. PubMed ID: 26423113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pros and cons of antibiotic therapy for pouchitis.
    Navaneethan U; Shen B
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):547-59. PubMed ID: 19817675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Quinolone-Resistant Mutations of gyrA and parC Genes after Pouchitis Treatment with Ciprofloxacin.
    Fukushima K; Saito T; Kohyama A; Watanabe K
    Dig Surg; 2020; 37(4):321-330. PubMed ID: 32182609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis in Metabolic Genes of the Gut Microbiomes of Patients with an Ileo-anal Pouch Resembles That Observed in Crohn's Disease.
    Dubinsky V; Reshef L; Rabinowitz K; Yadgar K; Godny L; Zonensain K; Wasserberg N; Dotan I; Gophna U
    mSystems; 2021 Mar; 6(2):. PubMed ID: 33653942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders.
    Barnes EL; Agrawal M; Syal G; Ananthakrishnan AN; Cohen BL; Haydek JP; Al Kazzi ES; Eisenstein S; Hashash JG; Sultan SS; Raffals LE; Singh S;
    Gastroenterology; 2024 Jan; 166(1):59-85. PubMed ID: 38128971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis and treatment of pouchitis in inflammatory bowel disease.
    Cheifetz A; Itzkowitz S
    J Clin Gastroenterol; 2004; 38(5 Suppl 1):S44-50. PubMed ID: 15115932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engraftment of essential functions through multiple fecal microbiota transplants in chronic antibiotic-resistant pouchitis-a case study using metatranscriptomics.
    Deng ZL; Pieper DH; Stallmach A; Steube A; Vital M; Reck M; Wagner-Döbler I
    Microbiome; 2023 Dec; 11(1):269. PubMed ID: 38037086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis.
    Suzuki H; Ogawa H; Shibata C; Haneda S; Watanabe K; Takahashi K; Funayama Y; Sasaki I
    Dis Colon Rectum; 2012 Mar; 55(3):330-6. PubMed ID: 22469801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trial.
    Trang-Poisson C; Kerdreux E; Poinas A; Planche L; Sokol H; Bemer P; Cabanas K; Hivernaud E; Biron L; Flet L; Montassier E; Le Garcasson G; Chiffoleau A; Jobert A; Lepelletier D; Caillon J; Le Pape P; Imbert BM; Bourreille A
    Trials; 2020 Jun; 21(1):455. PubMed ID: 32493442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.
    Hurst RD; Molinari M; Chung TP; Rubin M; Michelassi F
    Arch Surg; 1996 May; 131(5):497-500; discussion 501-2. PubMed ID: 8624195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antibiotics for treatment of inflammatory bowel disease.
    Nitzan O; Elias M; Peretz A; Saliba W
    World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with ileal mucosal morphology and inflammation in patients with ileal pouch-anal anastomosis for ulcerative colitis.
    Kuisma J; Mentula S; Luukkonen P; Jarvinen H; Kahri A; Farkkila M
    Dis Colon Rectum; 2003 Nov; 46(11):1476-83. PubMed ID: 14605565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Antibiotic Treatment in Pouchitis-Patterns of Use and Safety.
    Bar N; Avraham Y; Dubinsky V; Cohen NA; Weiss GA; Banon L; Tulchinsky H; Maharshak N; Gophna U; Dotan I
    Inflamm Bowel Dis; 2022 Jul; 28(7):1027-1033. PubMed ID: 34536075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
    Singh S; Stroud AM; Holubar SD; Sandborn WJ; Pardi DS
    Cochrane Database Syst Rev; 2015 Nov; (11):CD001176. PubMed ID: 26593456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal coliform testing to identify effective antibiotic therapies for patients with antibiotic-resistant pouchitis.
    McLaughlin SD; Clark SK; Shafi S; Petrovska L; Tekkis PP; Ciclitira PJ; Nicholls RJ
    Clin Gastroenterol Hepatol; 2009 May; 7(5):545-8. PubMed ID: 19418603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis.
    Duffy M; O'Mahony L; Coffey JC; Collins JK; Shanahan F; Redmond HP; Kirwan WO
    Dis Colon Rectum; 2002 Mar; 45(3):384-8. PubMed ID: 12068199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.